Totally [Fe]rocious's main goal was to stealthily kill Klebsiella pneumoniae using the siderophore aerobactin coupled to a gold nanoparticle. We decided to synthesize aerobactin in Escherichia coli and planned to use the conjugated aerobactin in a limited iron environment —to mimic an infectious site— and activate the complex ¨Fe3+ - aerobactin -AuNPs with a near-infrared (NIR) laser. To achieve this goal, we had multiple aims for the Wet and Dry lab parts using the Design-Build-Test-Learn (DBTL) cycle. For the Wet lab section, we aimed to amplify, assemble and synthesize aerobactin using an optimized E. coli strain before binding the AuNPs to the aerobactin to create our Trojan Horse. As for the Dry lab, our goal was to gain a deeper understanding of the siderophore internalisation mechanisms in order to ensure that the incorporation of an additional foreign moiety into the siderophore would not disrupt its uptake. This enhanced understanding could also help optimize the “Trojan Horse” strategy and facilitate the efficient delivery of modified siderophores into bacteria.
The foundation of Totally [Fe]rocious was built upon the aerobactin gene: iucA to D from K. pneumoniae's siderophore aerobactin. It is a siderophore used by many bacteria. These genes were used to recreate the biosynthesis pathways of aerobactin in an optimized E. coli strain DH5𝞪. These genes, the iucA Citryl transferase, the iucB N⁶-acetyltransferase, the iucC Citryl transferase and the iucD L-lysine N⁶-monooxygenase have the potential to recreate the exact, and recognizable, siderophore in another bacteria before binding it with gold nanoparticles and destroying them from the inside-out.
Aerobactin from K. pneumoniae is a hydroxamate-type siderophore and can also be considered as a “xenosiderophore” because of its capability of being accepted as an active siderophore by other bacteria.
Considering the difficulty and limitations of our project, we set out to use E. coli DH5𝞪 before thinking of using K. pneumoniae. In that regard, we optimized each gene part to be in another bacteria than its original one. We also needed a way to observe if the construction that we have made was expressed or present in the DH5𝞪. For this, we decided to use the plasmid pBluescript a vector for our Gibson Assembly. This means that our aerobactin pathway was assembled in the pBluescript plasmid before we transformed our DH5𝞪 to express one of each of both colours: blue or white in the presence of IPTG in the petri dish.
The iucA gene from K. pneumoniae has a length of 1395bp and initiates the core biosynthesis pathway of aerobactin. It requires citrate to be able to ligate this product as a first molecule (see the contribution/parts section or BBa_256Z6XQY). We designed the iucA gene with a TAC promoter, a random sequence and an RBS (Bba_0029) upstream of the start codon of iucA.
The iucB gene from K. pneumoniae has a length of 945bp and performs the second and final enzymatic step in the biosynthesis (see the contribution/parts section or BBa_253NP2T0). We designed the iucB gene with a spacer between the iucA and iucB genes, plus an RBS (Bba_B0030) upstream of its sequence.
The iucC gene from K. pneumoniae has a length of 1779bp and acts as the second citryl transferase after iucA. It also carries the final biochemical reaction in the biosynthesis pathway (see the contribution/parts section or BBa_25TEHQLR). We designed the iucC> sequence with a spacer between iucB and iucC with an RBS (Bba_B0032) upstream of the gene sequence.
The iucD gene from K. pneumoniae has a length of 1332bp and catalyzes the first step in the biosynthesis of ahLys (see the contribution/parts section or BBa_255DLKJB). We designed the iucD sequence with a spacer between iucC and iucD with an RBS (Bba_B0064) upstream of the sequence, and put a terminator at the end with a random sequence.
With all these parts, we obtained the reference sequence that is the IucABCD-assembly: BBa_25ZGK3Y5.
To optimize the in-silico production of aerobactin, our first design objective was to identify the environment and genetic conditions that maximize intracellular citrate availability - the initial building block of our siderophore. We selected E. coli as the chassis for heterologous expression of its well characterized metabolism and availability of validated genome-scale models.
We used the iML1515 model, which includes 1516 genes and over 2700 metabolic reactions, as the foundation for our simulations. Our design variables included:
We hypothesized that low pH, alternative carbon sources, and specific knockouts could increase citrate accumulation at the expense of biomass growth, a desired trade-off for metabolic overproduction.
At the core of this project lies the set of protein sequences essential to address our research questions. Most notably, these include the four proteins responsible for siderophore biosynthesis, as well as the sequences of the TBDT and TonB. However, limited information was available in the literature regarding siderophore-associated proteins in K. pneumonia. Our initial objective was therefore to gather as much structural information as possible, particularly on the TBDT, to ensure that our prediction closely reflects the naive configuration observed in nature.
To achieve this, one of our first steps was to translate the extensive knowledge available for E. coli to our organism of interest. Leveraging the high structural conservation of TBDTs and other related proteins, we used BLASTp [2] searches restricted to K. pneumonia (taxid:573) to identify homologous sequences. As for aerobactin, our siderophore of interest, its Simplified Molecular Input Line Entry System (SMILE) code was available on PubChem [3]. Additionally, we sought information on potential post-translational modifications (PTMs), disulfide bridges, and functional domains within the TBDT to provide key insights for subsequent analyses throughout the iGEM project cycle.
In order to model the TBDT within a bacterial membrane, several additional questions needed to be addressed to ensure the accuracy of the system. Having already identified the TBDT’s sequence and structure, the next considerations concerned the composition of the bacterial membrane and the surrounding solution. Facing the same challenge of limited information available for K. pneumonia, we opted to use a generic Gram-negative membrane composition [4]. For its part, the solution was supplemented with Na+ and Cl- ions, as these are among the most abundant ions found in biological environments. Finally, the CHARMM-GUI [5] platform was selected to construct our systems, given its extensive set of tools and flexibility for various molecular dynamic modelling approaches.
1. pBluescript “backbone” Extraction [6]: We used an extraction technique to extract the pBluescript plasmid from a liquid bacterial culture using the Quiagen kit: QUIAprep spin miniprep kit.
2. pBluescript Digestion and Linearization [6]: We used the HindIII-HF enzyme to digest the plasmid and obtain its linear version that we eventually used for the Gibson Assembly.
3. pBluescript Cleaning [6]: After the digestion with the HindIII-HF enzyme, we cleaned up the DNA with the “BioBasic: EZ-10 Spin Column DNA Cleanup Miniprep Kit” to purify the DNA and remove unwanted components (contaminants).
4. pBluescript Electrophoresis [6]: After the clean-up, we put the DNA on a 0.8% agarose gel to observe if we had isolated the pBluescript plasmid in its linear form.
5. Oligo Resuspension: We resuspended our gBlocks oligos, along with their forward and reverse primers, to a specific concentration.
6. gBlock PCR Amplification [6.a]: We then used our resuspended oligos and amplified our gBlocks to add the homology arms necessary for Gibson assembly.
7. PCR Electrophoresis [6]: Using the same agarose gel recipe from before, we put our gBlock amplification on the gel to see if it had worked.
8. PCR Touchdown: We needed to upgrade our specificity for the third gBlock, to achieve that, we tried the PCR Touchdown method. This method works by having a higher temperature in the first 9 cycles before dropping at a rate of minus 1 degree Celsius per cycle all the way down to the primers' optimal annealing temperature.
9. Gibson Assembly [6.b]: Our goal was to assemble all of our gBlocks in the pBluescript plasmid, and for that, we used the Gibson assembly kit and method.
10. Chemical Transformation of Competent Cells [6.c]: Using the E. coli strain DH5α, we transformed our competent cells with the Gibson assembly product before putting our transformation product on a petri dish culture. After 24h at 37℃, the clones that worked were white, and those that didn’t transform were blue (from the pBluescript plasmid).
11. Plasmid Extraction [6]: We extracted the plasmid from positive mutants using the “QIAgen - QIAprep spin miniprep kit” to be digested afterward.
12. Digestion of Assembled Plasmid [6]: After the plasmid extraction, we digested our plasmid construction to see if the Gibson assembly worked, using the BamI-HF and the EcoRI enzymes.
13. Subsequent Amplification: Before proceeding to the next step of our project, we needed the Gibson assembly to work, and for that, we needed the third gBlock to amplify in PCR. We then tried the inverse touchdown PCR method on the gBlock and the stitching PCR method.
14. Competent Cells [6.c]: After several cycles of troubleshooting, we finally tried to make our own competent cells to then assemble our gBlocks.
The computational model was built and parameterized using the COBRApy Python package, which enables constraint-based reconstruction and analysis of genome-scale networks. We implemented flux balance analysis (FBA) to calculate steady-state flux distributions maximising either growth or citrate export to assess pathway flexibility [7].
We simulated multiple conditions by systematically varying media composition and environmental parameters, applying gene knockouts, and recording resulting fluxes for:
Prediction of the siderophore aerobactin was performed using Chai-1 [8], which accepts SMILEs strings as valid ligand inputs. The TBDT structure was predicted using both the Chai-1 and Alphafold3 [9] servers. Since both accept the one letter code of amino acid, it permitted us to assert a sort of consensus on the resulting prediction. Residue-level predictions of membrane embedding were obtained using the OPM web server [10].
Using the information gathered during the Design phase, along with the predicted 3D structure of TBDT, we constructed a model representing the in vivo composition of a Gram-negative bacteria membrane with the TBDT embedded at its core. The system was further surrounded by a sufficiently large water box to minimize potential interaction artifacts and supplemented with the appropriate ions. CHARMM-GUI provided the system, its parameters, and the optimized force field, enabling a high-quality and physically realistic model for subsequent simulations.
*From this point forward, the test and learn section for the wet lab are hypotheses about what the next steps should be about and what we could learn from them.*
With our assembled plasmid carrying the three gBlocks, and within them all the necessary genes to produce and export the aerobactin siderophore, the next step would be to put the bacterial strain in a rich citrate environment to induce the production of aerobactin. Within the culture, we would need to detect the presence of siderophores using Mass-Spectrometry (MS) and other chemical tests for the hydroxamate siderophore-type, like the Csaky Test that depends on the formation of NO2- via the oxidation of hydroxylamine (NH2OH) by an iodine solution and the formation of colored dye, the Ferric Perchlorate Assay that identifies, by the appearance of an orange-red or purple color, the hydroxamate-type siderophores when putting Fe3+ ion and low pH perchloric acid in the test tube, or the Tetrazolium Test that only uses a few drops of NaOH and the sample to the tetrazolium salt creating a deep-red color [11]. Eventually, we would need to conjugate our siderophore to a gold nanoparticle to try and find a way to activate the complex aerobactin-Fe3+-AuNP inside K. pneumoniae.
Simulations showed that maximum citrate secretion (18.17 mmol/gDW/h) occurred under acidic conditions (pH ≈ 5) with glycerol as the carbon source and Pi as the nitrogen source. In contrast, the wild-type (WT) model consistently achieved the highest growth rate (~1.85 h⁻¹) under neutral pH with ammonium, confirming a clear metabolic trade-off between citrate production and biomass formation.
We used NAMD [11] to simulate three independent replicates of the TBDT system with the domain, as well as a second set of three replicates without the plug domain, each for a minimum duration of 350 ns for each trajectories. Upon completion of the simulations, the membrane systems trajectories were visualized using VMD (Visual Molecular Dynamics) [13]. Finally, most computational analyses were performed using Wordom [14].
Our Wet lab experiments were cut short because of our inability to assemble our three gBlocks into a functional plasmid. However, the entire sequence should be revised to know why the third gBlock is so difficult to amplify before trying any PCR methods. We suspect having some more difficulties with the expression of the siderophore and the conjugation with the AuNPs, but nothing unachievable. The expected results should be the successful binding of the siderophore-AuNPs and the formation of the aerobactin-Fe3+-AuNP complex that will use the TBDT-TonB system to enter K. pneumoniae. After this step, we should be able to activate the complex with a NIR laser (808nm) that would be absorbed by both AuNPs and K. pneumoniae. The NIR laser would activate the conjugate AuNPs that will, then, vibrate, produce heat and induce cellular lysis.
By then, we suppose that we will have learned if the use of a NIR laser is effective or if another method should be used, whether the AuNPs are optimal for the binding and whether the lysis effect is the one that the Totally [Fe]rocious team aimed for.
From this first modelling iteration, we learned that citrate accumulation can be enhanced in acidic, glycerol-rich environments but at the cost of growth. This insight indicates that two-stage fermentation strategy: first growing cells in neutral conditions, then switching to acidic media for production would likely optimize total aerobactin yield. We also learned that maintaining siderophore flux despite ICDHyr deletion suggests possible redundancy in the citrate synthesis routes, warranting further exploration via flux variability analysis and double knockouts.
The dry lab investigation of the plug domain’s contribution to the TBDT structure provided valuable insights at the residue level, clarifying how its presence influences the β-barrel and overall protein stability. However, a more rigorous experimental design could have yielded a stronger dataset to analyse. Initiating the calculation earlier on, for instance, would have enabled the generation of longer trajectories, allowing for the observation of more stable protein conformations, even within the limited timeframe of an iGEM cycle. Similarly, increasing the number of replicates to five would provide us a clearer picture of the interactions governing the TBDT dynamics and its plug domain.
The scope of our research was also constrained by the absence of parametrization for the siderophore-Fe3+ complex. Future work could focus on developing optimized parameters for various siderophores in complexes with Fe3+, enabling the study of a broader range of bacterial systems. Incorporating these newly parametrized complexes into simulations would provide a deeper insight into the molecular interactions governing siderophore translocation through the TBDT. Ultimately, this would improve our understanding of the siderophore transport across the outer membrane and could extend to characterizing their crossing through the inner membrane, across an ABC transporter.